Personalised cancer medicine is advancing, but better biomarker testing, clinical [...]

Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

Telix has agreed to acquire ITM Isotope Technologies Munich in [...]

MaaT Pharma plans to advance a global Phase 3 trial [...]

Early Phase 1b data show five objective responses among six [...]

START and Allegheny Health Network are establishing a new early-phase [...]

Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

A new AI model has generated patient-specific radiation dose-rate maps [...]

Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

Telix has dosed the first patient in a Phase 3 [...]